Search

Search Constraints

You searched for: Author/Creator Fei, Keke

Search Results

3. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. Issue 8 (17th November 2019)

4. IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma. (28th June 2022)